TALENTUM BOARD OF DIRECTORS’ PROPOSALS TO THE ANNUAL

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
TALENTUM BOARD OF DIRECTORS’ PROPOSALS TO THE ANNUAL GENERAL MEETING

Helsinki, Finland, 2015-02-12 07:35 CET (GLOBE NEWSWIRE) --  

Talentum Oyj       Stock Exchange Release       12 February 2015, at 8.35 a.m.

TALENTUM BOARD OF DIRECTORS’ PROPOSALS TO THE ANNUAL GENERAL MEETING

Talentum Board of Directors convenes the Annual General Meeting to be held on March 27, 2015. The Annual General Meeting shall be held starting at 2 p.m. at Talentum head office auditorium, address Itämerenkatu 23, 00180 Helsinki.

The notice of the Annual General Meeting will be published as a stock exchange release on March 5, 2015 and on the company’s website at www.talentum.com. A summary of the notice will be published in Tekniikka & Talous magazine and Talouselämä magazine on March 13, 2015.

In addition to the matters stated in the Companies Act and Articles of Association, the following proposals of the Board of Directors shall be addressed in the Annual General Meeting:

THE PROPOSAL OF THE BOARD OF DIRECTORS OF TALENTUM OYJ TO THE ANNUAL GENERAL MEETING ON MARCH 27, 2015 REGARDING THE AUDITOR, AUDITOR'S FEE AND BASIS FOR REIMBURSEMENT OF EXPENSES

The Board of Directors proposes to the Annual General Meeting that Authorised Public Accountants PricewaterhouseCoopers Oy be re-elected as the company's Auditor. PricewaterhouseCoopers Oy has informed that the auditor with principal responsibility would be Authorized Public Accountant Samuli Perälä.

The Board of Directors proposes to the Annual General Meeting that the Auditor's fee and compensation for costs will be paid as invoiced and accepted by the company.

THE PROPOSAL OF THE BOARD OF DIRECTORS OF TALENTUM OYJ TO THE ANNUAL GENERAL MEETING ON MARCH 27, 2015, REGARDING THE AUTHORIZATIONS TO THE BOARD OF DIRECTORS TO DECIDE ON ACQUISITION OF OWN SHARES

The Board of Directors proposes to the General Meeting that the General Meeting would authorize the Board of Directors, cancelling the previous authority, to decide on acquisition of own shares, including acceptance as pledge of own shares. The shares could be acquired for the value decided by the Board of Directors, which value is based on the fair value at the time of the acquisition formed to the shares in the public trading. Own shares may be only acquired with free equity. Based on the authorization, either in one or in several occasions, a maximum of 3,500,000 own shares, which correspond to approximately eight (8) per cent of the issued and outstanding shares of the company, could be acquired. The authorization would remain in force until June 30, 2016. The Board of Directors is otherwise authorized to decide on all the conditions regarding the acquisition of own shares including the manner of acquisition of shares. The authorization does not exclude the right of the Board of Directors to also decide on a directed acquisition of own shares providing that there is a significant financial reason for the company to do so.

THE PROPOSAL OF THE BOARD OF DIRECTORS OF TALENTUM OYJ TO THE ANNUAL GENERAL MEETING ON MARCH 27, 2015, REGARDING THE AUTHORIZATIONS TO THE BOARD OF DIRECTORS TO DECIDE ON SHARE ISSUE INCLUDING THE CONVEYANCE OF OWN SHARES, AND ISSUE OF SPECIAL RIGHTS

The Board of Directors proposes to the General Meeting, that the General Meeting would authorize the Board of Directors to decide, cancelling the previous authority, on a share issue which may be either liable to charge or free of charge, including issuing of new shares and the conveyance of own shares possibly in the company's possession and the realisation of own shares accepted as pledge. The Board of Directors proposes to the General Meeting that it would authorize the Board of Directors to decide on an issue of option rights and other special rights which entitle, against payment, to receive new shares or shares possibly in possession of the company. Based on the aforesaid authorizations by virtue of a share issue and/or issue of special rights, either in one or in several occasions, a maximum of 3,500,000 new shares may be issued and/or own shares possessed by the company may be conveyed, which corresponds to approximately eight (8) per cent of the issued and outstanding shares of the company. The authorizations would remain in force until June 30, 2016. The authorizations do not exclude the right of the Board of Directors to also decide on a directed share issue and directed issue of special rights. Shareholders' pre-emptive subscription rights can be deviated from providing that there is a significant financial reason for the company to do so.

THE PROPOSAL OF THE BOARD OF DIRECTORS OF TALENTUM OYJ, TO THE ANNUAL GENERAL MEETING ON MARCH 27, 2015, FOR THE DISTRIBUTION OF DIVIDEND

The Board of Directors proposes to the Annual General Meeting that a dividend in the amount of EUR 0.05 to be distributed for financial year 1 January 2014 - 31 December 2014 (for 2013 a dividend in the amount of EUR 0.04 per share was distributed).

THE PROPOSAL OF THE BOARD OF DIRECTORS OF TALENTUM OYJ, TO THE ANNUAL GENERAL MEETING ON MARCH 27, 2015, REGARDING THE AUTHORIZATIONS TO THE BOARD OF DIRECTORS TO DECIDE ON THE DISTRIBUTION OF ADDITIONAL DIVIDEND OR THE DISTRIBUTION OF ASSETS FROM THE RESERVES OF UNRESTRICTED EQUITY

The Board of Directors proposes to the General Meeting that the General Meeting would authorize the Board of Directors to decide, cancelling the previous authority, on the distribution of additional dividend from the retained earnings and/or distribution of assets from the reserve of invested unrestricted equity or both so that the distribution of dividend and/or other distribution of assets based on the authorisation would be in total a maximum of EUR 0.20 per share. The distribution of additional dividend and/or other distribution of assets could be made in one or more instalments. The authorizations would remain in force until the beginning of the next Annual General Meeting. The Board of Directors is otherwise authorized to decide on all the conditions regarding the distribution of additional dividend and/or other distribution of assets.


Helsinki, February 11, 2015

THE BOARD OF DIRECTORS

TALENTUM OYJ
Aarne Aktan
CEO

FURTHER INFORMATION
CEO Aarne Aktan, tel. +358(0)40 342 4440

DISTRIBUTION
NASDAQ OMX Helsinki
Principal media
www.talentum.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 41

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 36

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 32

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 37

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Growth of Middle-Class Investors through Mutual Fund Ownership

Updated Category News Views 149

Mutual Funds and the Rise of the Middle-Class Investor Over recent years, mutual fund ownership has surged among middle-class families. According to insights from the Investment Company Institute (ICI), this trend signifies a vital transition as middle-income households increasingly seek investment opportunities. The growing presence of mutual funds in the American...

Continue Reading
Rques Exchange Reinforces Its Brand with Compliance Strategy

Updated Category News Views 180

Rques Exchange Reinforces Brand with Regulatory Frameworks Rques Exchange is taking significant steps to enhance its brand by emphasizing its commitment to regulatory alignment, operational transparency, and governance integrity in various markets. With global authorities increasingly scrutinizing digital asset platforms, Rques aims to position itself as a technology...

Continue Reading
Business Growth and Confidence: Provident Bank's Insights

Updated Category News Views 120

Increasing Business Confidence for the Future Recently, Provident Bank, a prominent financial institution based in New Jersey, conducted an enlightening Economic Outlook survey. This survey reflects the sentiments of 1,000 business leaders regarding the 2025 economic prospects. The results showcase a robust sense of optimism and confidence among businesses as they look...

Continue Reading
Performance Food Group Co: A Five-Year Stock Journey

Updated Category News Views 219

Unlocking the Value of Investment in Performance Food Group Co Performance Food Group Co (NYSE: PFGC) has delivered impressive returns over the last five years, standing out in the competitive market landscape. With an annualized return that has surpassed the market by 9.42%, investors have seen an average growth rate of around 24.5%. This stock is not just another entry...

Continue Reading
Understanding Rathbones Group Plc's Disclosure Requirements

Updated Category News Views 227

Key Information on Disclosure Requirements Understanding how companies disclose their shareholding is crucial for investors and stakeholders alike. Rathbones Group Plc plays an essential role in managing these disclosures, particularly regarding relevant securities that represent substantial interests in listed companies. Full Name of the Discloser The full name of the...

Continue Reading